ACRO BIOMEDICAL CO., LTD. (ACBM)
↓ Download CSV- Sector Services
- Incorporated NV
- Fiscal year ends Dec 31
In fiscal 2025, ACRO BIOMEDICAL CO., LTD. reported revenue of $0. The company ran a net loss.
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $658.5K | $1.20M | — | — | — | $510.0K | — |
| Cost of Revenue | — | — | $0 | $518.0K | $938.0K | $528.6K | $181.4K | $7.18M | $459.0K | — |
| Gross Profit | — | — | $0 | $140.5K | $259.5K | $159.4K | $12.1K | $833.4K | $51.0K | — |
| Operating Income | -$154.0K | -$38.0K | -$8.80M | -$15.87M | -$7.69M | -$130.5K | -$422.8K | $515.5K | -$2.2K | $43.4K |
| Net Income | -$101.1K | -$42.3K | -$8.81M | -$15.87M | -$7.70M | -$117.5K | -$371.6K | $419.7K | -$2.2K | -$43.4K |
| EPS (Diluted) | $0.00 | $0.00 | $-0.15 | $-0.26 | — | — | — | — | — | — |
| Total Assets | $14.1K | $32.0K | $58.5K | $687.5K | $761.1K | $998.1K | $932.1K | $1.48M | $548.3K | $2.5K |
| Total Liabilities | — | $326.9K | $315.5K | $201.1K | $117.4K | $312.2K | $133.9K | $240.7K | $37.0K | $17.3K |
| Shareholders' Equity | -$387.0K | -$295.0K | -$257.0K | $486.4K | $643.7K | $685.9K | $798.2K | $1.17M | $511.3K | -$14.8K |
| Cash & Equivalents | — | — | — | — | — | $18.1K | $911 | $37.6K | $36.8K | $2.5K |
| Operating Cash Flow | -$196.3K | -$36.7K | -$15.4K | -$147.5K | $299.3K | -$199.5K | -$59.7K | -$140.4K | -$463.3K | — |
| Shares Outstanding | 60.04M | 60.04M | 60.04M | 60.04M | 60.04M | 47.76M | 47.76M | 47.76M | 47.66M | 47.16M |